<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – SBIR Overview</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I overview: problem, innovation, aims, and feasibility."/>
  <style>
    *{ box-sizing:border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    /* ===== Shared Header / Nav ===== */
    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px;
      margin:0 auto;
      padding:14px 20px;
      display:flex;
      align-items:center;
      justify-content:space-between;
      gap:18px;
      flex-wrap:wrap;
    }
    .nav-left{
      display:flex;
      align-items:center;
      gap:12px;
    }
    .logo-dot{
      width:28px;
      height:28px;
      border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{
      font-size:1.1rem;
      font-weight:650;
      letter-spacing:.04em;
    }
    .subbrand{
      font-size:.72rem;
      color:#9ca3af;
      margin-top:2px;
    }

    .nav-links{
      display:flex;
      gap:10px;
      flex-wrap:wrap;
      justify-content:flex-end;
    }
    .nav-links a{
      font-size:.88rem;
      color:#9ca3af;
      padding:6px 10px;
      border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    /* ===== Layout ===== */
    main{ flex:1; }
    .section{
      max-width:1120px;
      margin:0 auto;
      padding:28px 20px;
    }
    .topline{
      display:flex;
      flex-wrap:wrap;
      gap:10px;
      align-items:flex-end;
      justify-content:space-between;
      padding-top:16px;
      margin-bottom:14px;
    }
    .doc-title{
      font-size:1.45rem;
      font-weight:820;
      color:#f9fafb;
      margin:0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size:.78rem;
      text-transform:uppercase;
      letter-spacing:.18em;
      color:#a5b4fc;
      margin-bottom:6px;
    }
    h2{
      font-size:1.15rem;
      font-weight:760;
      color:#f9fafb;
      margin:14px 0 8px;
    }
    p{
      margin:0 0 10px;
      font-size:.93rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns:minmax(0,1.05fr) minmax(0,1fr);
      gap:18px;
      align-items:start;
      margin-top:10px;
    }
    .card{
      border-radius:16px;
      padding:14px 16px;
      background: rgba(15,23,42,0.84);
      border:1px solid rgba(148,163,184,0.28);
      box-shadow:0 18px 45px rgba(15,23,42,0.55);
    }
    .card h3{
      margin:0 0 8px;
      font-size:.95rem;
      letter-spacing:.14em;
      text-transform:uppercase;
      color:#a5b4fc;
    }

    ul{
      margin:6px 0 0;
      padding-left:1.1rem;
      color:#d1d5db;
      font-size:.92rem;
    }
    li{ margin-bottom:6px; }
    li strong{ color:#e5e7eb; }

    .callout{
      border-radius:14px;
      padding:12px 14px;
      border:1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size:.88rem;
      color:#e5e7eb;
      margin-top:12px;
    }
    .callout strong{ color:#22c55e; }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width:920px){
      .grid-2{ grid-template-columns:minmax(0,1fr); }
    }

    @media print{
      header, footer{ display:none !important; }
      body{ background:#fff; color:#111; }
      p, li{ color:#111; }
      .kicker, .card h3{ color:#111; }
      .card, .callout{ background:#fff; box-shadow:none; }
      .section{ max-width:100%; padding:0; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>

      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html" class="active">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">SBIR Phase I Overview</h1>
        <div class="meta">
          PromptGenix LLC · Women & Minority-Owned · Contact: dohoon.kim1@icloud.com
        </div>
      </div>

      <div class="kicker">The problem</div>
      <h2>Biomedical data generation outpaces analysis and interpretation.</h2>
      <p>
        NIH-funded laboratories routinely generate RNA-Seq, scRNA-Seq, and high-dimensional flow cytometry data,
        yet analysis remains fragmented across tools and scripts. Turnaround is slow, reproducibility is inconsistent,
        and scientific interpretation depends on limited expert bandwidth.
      </p>

      <div class="kicker">The innovation</div>
      <h2>PromptGenix: an automated BioAI co-investigator.</h2>
      <p>
        PromptGenix integrates reproducible analysis pipelines with a literature-aware AI layer that produces
        human-readable summaries, ranked biological hypotheses, and concrete follow-up experiments.
        The platform transforms raw FASTQ and FCS files into actionable, reviewer-ready outputs.
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>Technical innovation</h3>
          <ul>
            <li><strong>End-to-end automation:</strong> RNA-Seq and flow cytometry pipelines with standardized outputs</li>
            <li><strong>Reproducibility:</strong> deterministic configurations and versioned reports</li>
            <li><strong>BioAI layer:</strong> hypothesis generation grounded in observed signals and PubMed evidence</li>
            <li><strong>Deployment flexibility:</strong> local-first execution with optional secure cloud scaling</li>
          </ul>
        </div>

        <div class="card">
          <h3>SBIR Phase I focus</h3>
          <ul>
            <li>Harden pipelines on multiple public datasets (GEO, SRA, FlowRepository)</li>
            <li>Validate hypothesis generator traceability and usefulness</li>
            <li>Measure reductions in turnaround time and improvements in reproducibility</li>
            <li>Produce reviewer-ready HTML/PDF reports</li>
          </ul>
          <div class="callout">
            <strong>Boundary:</strong> Phase I validation uses public data only to avoid IP and data-use constraints.
          </div>
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Why it matters</div>
      <h2>Faster, more interpretable science with lower operational burden.</h2>
      <p>
        By automating analysis and embedding scientific reasoning directly into the workflow, PromptGenix enables
        small and mid-sized labs to operate with PI-level analytical capacity. The result is faster insight generation,
        improved rigor, and clearer decision-making for experimental design.
      </p>

      <div class="callout">
        <strong>Commercial relevance:</strong> the same capabilities validated in Phase I directly support a scalable
        commercialization path to academic labs, CROs, and government research groups in Phase II.
      </div>
    </section>
  </main>

  <footer>
    PromptGenix · SBIR Portal ·
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
